{
 "drug": "Mirikizumab-mrkz Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "12/22/2025",
 "dayN": 246,
 "cat": "Gastroenterology",
 "companies": [
  "Eli Lilly and Co."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "12/22/2025",
   "update_type": "New",
   "initial_posting_date": "12/22/2025",
   "package_ndc": "0002-8870-27",
   "generic_name": "Mirikizumab-mrkz Injection",
   "contact_info": "800-545-5979",
   "related_info": "A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-1442-11) will remain.",
   "openfda": {
    "application_number": [
     "BLA761279"
    ],
    "brand_name": [
     "OMVOH"
    ],
    "generic_name": [
     "MIRIKIZUMAB-MRKZ"
    ],
    "manufacturer_name": [
     "Eli Lilly and Company"
    ],
    "product_ndc": [
     "0002-8870",
     "0002-7575",
     "0002-8011",
     "0002-7717",
     "0002-7722",
     "0002-3116",
     "0002-1442"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "MIRIKIZUMAB"
    ],
    "rxcui": [
     "2668391",
     "2668398",
     "2668405",
     "2668410",
     "2680728",
     "2680732",
     "2703047",
     "2703048",
     "2703049",
     "2703050",
     "2703051",
     "2703052",
     "2703053",
     "2703054"
    ],
    "spl_id": [
     "3553ca93-cbe0-4286-b806-a423598eb42a"
    ],
    "spl_set_id": [
     "472cbe04-263e-433d-9a0f-58c1b50b715a"
    ],
    "package_ndc": [
     "0002-7575-01",
     "0002-8011-01",
     "0002-8011-27",
     "0002-8011-61",
     "0002-8870-01",
     "0002-8870-27",
     "0002-7717-11",
     "0002-7717-61",
     "0002-3116-01",
     "0002-7722-11",
     "0002-1442-01",
     "0002-3116-11",
     "0002-3116-61",
     "0002-1442-11"
    ],
    "nui": [
     "N0000192799",
     "N0000192798"
    ],
    "pharm_class_epc": [
     "Interleukin-23 Antagonist [EPC]"
    ],
    "pharm_class_moa": [
     "Interleukin-23 Antagonists [MoA]"
    ],
    "unii": [
     "Z7HVY03PHP"
    ]
   },
   "update_date": "12/22/2025",
   "therapeutic_category": [
    "Gastroenterology",
    "Other"
   ],
   "dosage_form": "Injection",
   "presentation": "Omvoh, Injection, 100 mg/1 mL (NDC 0002-8870-27)",
   "company_name": "Eli Lilly and Co.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "12/22/2025",
   "update_type": "New",
   "initial_posting_date": "12/22/2025",
   "package_ndc": "0002-8011-27",
   "generic_name": "Mirikizumab-mrkz Injection",
   "contact_info": "800-545-5979",
   "related_info": "A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-3116-11) will remain.",
   "openfda": {
    "application_number": [
     "BLA761279"
    ],
    "brand_name": [
     "OMVOH"
    ],
    "generic_name": [
     "MIRIKIZUMAB-MRKZ"
    ],
    "manufacturer_name": [
     "Eli Lilly and Company"
    ],
    "product_ndc": [
     "0002-8011",
     "0002-7575",
     "0002-8870",
     "0002-7717",
     "0002-7722",
     "0002-3116",
     "0002-1442"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "MIRIKIZUMAB"
    ],
    "rxcui": [
     "2668391",
     "2668398",
     "2668405",
     "2668410",
     "2680728",
     "2680732",
     "2703047",
     "2703048",
     "2703049",
     "2703050",
     "2703051",
     "2703052",
     "2703053",
     "2703054"
    ],
    "spl_id": [
     "3553ca93-cbe0-4286-b806-a423598eb42a"
    ],
    "spl_set_id": [
     "472cbe04-263e-433d-9a0f-58c1b50b715a"
    ],
    "package_ndc": [
     "0002-7575-01",
     "0002-8011-01",
     "0002-8011-27",
     "0002-8011-61",
     "0002-8870-01",
     "0002-8870-27",
     "0002-7717-11",
     "0002-7717-61",
     "0002-3116-01",
     "0002-7722-11",
     "0002-1442-01",
     "0002-3116-11",
     "0002-3116-61",
     "0002-1442-11"
    ],
    "nui": [
     "N0000192799",
     "N0000192798"
    ],
    "pharm_class_epc": [
     "Interleukin-23 Antagonist [EPC]"
    ],
    "pharm_class_moa": [
     "Interleukin-23 Antagonists [MoA]"
    ],
    "unii": [
     "Z7HVY03PHP"
    ]
   },
   "update_date": "12/22/2025",
   "therapeutic_category": [
    "Gastroenterology",
    "Other"
   ],
   "dosage_form": "Injection",
   "presentation": "Omvoh, Injection, 100 mg/1 mL (NDC 0002-8011-27)",
   "company_name": "Eli Lilly and Co.",
   "status": "To Be Discontinued"
  }
 ]
}